Evaluating the therapeutic efficacy of Grb2 inhibition in ovarian malignanciesOlivia D. Lara(The University of Texas MD Anderson Cancer Center)Digital Commons-TMC (Texas Medical Center)January 1, 2019Cited by 0SaveCiteExport RISWatch citationsRelated PapersTherapeutic efficacy of liposomal Grb2 antisense oligodeoxynucleotide (L-Grb2) in preclinical models of ovarian and uterine cancer|Oncotarget|2020|10SPL-108 mitigates metastasis and chemoresistance in tubo-ovarian carcinoma|Translational Oncology|2024|1